Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer

Bone Marrow Transplantation

Volumn 27, Issue 9, 2001, Pages 989-998

  Carlson, L E ^a   Koski, T ^b   Gluck S ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

^b Northeastern Ontario Regional Cancer Centre   (Canada)

Author keywords

ASCT; Breast cancer; FLIC; Metastatic; Prospective study; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; MITOXANTRONE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANXIETY; ARTHRALGIA; ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FAMILY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; METASTASIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SCORING SYSTEM; SEXUAL BEHAVIOR; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; ARTHRALGIA; BONE NEOPLASMS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DEPRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MIDDLE AGED; MITOXANTRONE; PACLITAXEL; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034992549     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703002     Document Type: Article

References (49)

1. A longitudinal study of the adjustment of patients and husbands to breast cancer
2. Depressive reactions to lung cancer are common and often followed by a poor outcome
3. Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advance malignancy
4. Is quality of life predictive of the survival of patients with advanced non-small cell lung carcinoma?
5. Endpoints in cancer clinical trials: Is there a need for measuring quality of life?
6. Quality of life as an endpoint in EORTC clinical trials
7. Guidelines for the assessment of quality of life in oncology - Implementing adequate methods and their content
8. Physicians' perspective on quality of life: An exploratory study of oncologists
9. The use of quality of live data in clinical practice
10. What value is given to quality of life assessment by health professionals considering response to palliative chemotherapy for advanced cancer?
11. A preliminary survey of oncologists perceptions of quality of life information
12. Impact of quality of life outcomes on clinical practice
13. Quality of life assessment in palliative care
14. A phase I trial of high-dose paclitaxel, cyclophosphamide and mitroxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer
15. Quality of life in adult bone marrow transplant patients: Beyond the first year
16. Quality of life after bone marrow transplantation
17. Autologous bone marrow transplantation for breast cancer
18. High dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
19. Quality of life (QL) assessment in patients with breast cancer surviving 12 months or more following high dose chemotherapy with autologous bone marrow transplant
20. Quality of life of long-term adult survivors of autologous bone marrow transplantation
21. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support
22. Coping strategies and psychological distress in cancer patients before autologous bone marrow transplant
23. Quality of life in breast cancer patients before and after autologous bone marrow transplantation
24. Health-related quality of life in women with breast cancer undergoing autologous stem-cell transplantation
25. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies
26. Dynamic assessment of quality of life after autologous bone marrow transplantation
27. Psychological support to an autologous bone marrow transplant unit in a community hospital: A pilot experience
28. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: A prospective study
29. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone
30. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study
31. Measuring the quality of life of cancer patients: The functional living index-cancer: Development and validation
32. Quality of life consequences of chemotherapy-induced emesis
33. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?
34. Psychosocial aspects of palliative care
35. Prevalence of psychological distress among cancer patients across the disease continuum
36. Quality of life (QOL) following high dose chemotherapy with autologous bone marrow support (HDC) in patients with metastatic breast cancer
37. Combination chemotherapy for metastatic or recurrent carcinoma of the breast -a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study
38. High dose chemotherapy with autologous blood stem cell transplantation: Increasing evidence for efficacy in patients with metastatic breast cancer
39. High dose chemotherapy with hematopoietic stem cell transplantation for metastatic breast cancer: Results of the French Protocol PEGASE 04
40. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
41. A randomized trial of high-dose chemotherapy and autologous stem cell therapy versus standard therapy in women with metastatic breast cancer who have responded to anthracycline or taxane-based induction chemotherapy
42. Effect of psychosocial treatment on survival of patients with breast cancer
43. Essentials of psychotherapeutic intervention for cancer patients
44. Group support for patients with metastatic cancer: A randomized prospective outcome study
45. Group cognitive behavioural therapy interventions with cancer patients: A review of the literature
46. A randomized wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients
47. Literature on interventions to address cancer patients' psychosocial needs: What does it tell us?
48. Cancer support groups and group therapies: Part I. Historical and theoretical background and research on effectiveness